XBiotech IPO Info
Company Name: XBiotech
Stock Symbol: XBIT
Exchange: NASDAQ
Status: Priced
IPO Date: 4/15/2015
IPO Price:
19.00 (
-42.79%)
Underwriters
WRHambrecht+Co
Amount of Offering: N/A
Number of Shares Offered: 4 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
XBiotech is a clinical-stage biopharmaceutical company engaged in discovering and developing 'True Human' monoclonal antibodies for treating a variety of diseases. True Human monoclonal antibodies are those which occur naturally in human beings as opposed to being derived from animal immunization or otherwise engineered. We believe that naturally occurring monoclonal antibodies have the potential to be safer and more effective than their non-naturally occurring counterparts. While focused on bringing our lead product candidate, Xilonix to market, we also have developed a True Human pipeline and manufacturing system.
News Headlines
